Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025)

Clinical trial NCT04031846 · COMPLETED

Trial details

NCT number: NCT04031846
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Infections

Start date: 2019-09-04
Primary completion: 2021-08-05
Enrollment: 1184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.